Elevated concentrations of lipoprotein(a) are not associated with adverse cardiovascular outcomes among patients with a recent acute coronary syndrome treated with statins, according to a new ...

As compared with what is known about predictors of vascular events in middle-aged persons, less is known about these events in the elderly. Lp(a) lipoprotein, which plays an important part in ...

Baseline lipoprotein a, or Lp(a), levels are strongly associated with major adverse cardiovascular events (MACE) in high-risk patients with elevated triglyceride levels receiving statin therapy, a new ...

Marking World Heart Day (September 29), Arnab Roy, Kshama Pimpalgaonkar, Abhik Banerjee, and Faisal Khan, Division of R&D and Department of Biochemistry; (SRL Mumbai) elaborate on the Indian phenotype ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Major adverse CV events were predicted in patients with recent ACS based on their lipoprotein(a) ...

Please provide your email address to receive an email when new articles are posted on . The risk for major adverse CV events after recent ACS could be predicted by baseline lipoprotein(a) and ...

Lp-PLA 2 is a novel enzyme that is believed to be involved in the formation of vulnerable, rupture-prone plaque and circulates in the blood attached to LDL cholesterol. It is found alongside and is ...